Fort Washington Investment Advisors Inc Abbott Laboratories Transaction History

Fort Washington Investment Advisors Inc

$16 Billion
Q3 2024

A detailed history of Fort Washington Investment Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 36,337 shares of ABT stock, worth $4.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

36,337

Previous 36,751 1.13%

Holding current value

$4.19 Million

Previous $3.82 Million 8.49%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $41,428 - $48,905	-414 Reduced 1.13%	36,337 $4.14 Million
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $3,727 - $4,160	37 Added 0.1%	36,751 $3.82 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $106,891 - $118,056	-976 Reduced 2.59%	36,714 $4.17 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $92,377 - $110,837	-967 Reduced 2.5%	37,690 $3.65 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $15,721 - $17,517	-156 Reduced 0.4%	38,657 $4.21 Million
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $13,172 - $15,505	-136 Reduced 0.35%	38,813 $3.93 Million
Q4 2022 Jan 30, 2023	BUY	$95.06 - $111.52 $296,111 - $347,384	3,115 Added 8.69%	38,949 $4.28 Million
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $214,807 - $248,706	-2,220 Reduced 5.83%	35,834 $3.47 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $219,960 - $265,862	2,155 Added 6.0%	38,054 $4.14 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $1.66 Million - $2.03 Million	-14,573 Reduced 28.87%	35,899 $4.25 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $73,823 - $90,392	639 Added 1.28%	50,472 $7.1 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $20,298 - $22,456	-174 Reduced 0.35%	49,833 $5.89 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $18,301 - $21,543	-173 Reduced 0.34%	50,007 $5.8 Million
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $799,974 - $942,490	-7,350 Reduced 12.78%	50,180 $6.01 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $162,435 - $177,007	-1,547 Reduced 2.62%	57,530 $6.3 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $59,840 - $72,672	653 Added 1.12%	59,077 $6.43 Million
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $26,799 - $34,300	-350 Reduced 0.6%	58,424 $5.34 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $58,548 - $85,613	-932 Reduced 1.56%	58,774 $4.64 Million
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $103,633 - $115,368	1,320 Added 2.26%	59,706 $5.19 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $2.58 Million - $2.8 Million	-31,568 Reduced 35.09%	58,386 $4.89 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $3.11 Million - $3.63 Million	-42,720 Reduced 32.2%	89,954 $7.57 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $385,863 - $466,509	-5,827 Reduced 4.21%	132,674 $10.6 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $2.18 Million - $2.47 Million	-33,297 Reduced 19.38%	138,501 $10 Million
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $48,343 - $58,321	-795 Reduced 0.46%	171,798 $12.6 Million
Q2 2018 Jul 27, 2018	SELL	$57.57 - $63.54 $14,622 - $16,139	-254 Reduced 0.15%	172,593 $10.5 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $1.85 Million - $2.1 Million	-32,954 Reduced 16.01%	172,847 $10.4 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $282,893 - $302,866	-5,270 Reduced 2.5%	205,801 $11.7 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $851,671 - $950,554	-17,721 Reduced 7.75%	211,071 $11.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	228,792	228,792 $11.1 Million

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Abbott Laboratories Transaction History